In addition, a study also proved that AHCY played important roles in hepatocellular carcinoma (HCC), and reduced AHCY activity caused adenosine depletion with activation of the DNA damage response, leading to cell cycle arrest, a decreased proliferation rate, and DNA damage [29], making AHCY a potential target for the treatment of HCC. This evidence concerns the gene AHCY and hepatocellular carcinoma.